China SXT Pharmaceuticals, Inc. (SXTC)
NASDAQ: SXTC · IEX Real-Time Price · USD
3.97
+1.90 (91.79%)
At close: Dec 29, 2023, 4:00 PM
2.72
-1.25 (-31.49%)
After-hours: Dec 29, 2023, 7:59 PM EST
China SXT Pharmaceuticals Market Cap
China SXT Pharmaceuticals has a market cap or net worth of $41.47 million as of December 29, 2023. Its market cap has increased by 3,670.13% in one year.
Market Cap
41.47M
Enterprise Value
27.86M
1-Year Change
3,670.13%
Ranking
Category
Stock Price
$3.97
Market Cap Chart
Since January 4, 2019, China SXT Pharmaceuticals's market cap has decreased from $129.20M to $41.47M, a decrease of -67.90%. That is a compound annual growth rate of -20.38%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Dec 29, 2023 | 1.80M | 100.00% |
Dec 28, 2023 | 900.00K | - |
Dec 27, 2023 | 900.00K | - |
Dec 26, 2023 | 900.00K | - |
Dec 22, 2023 | 900.00K | 12.50% |
Dec 21, 2023 | 800.00K | - |
Dec 20, 2023 | 800.00K | -11.11% |
Dec 19, 2023 | 900.00K | - |
Dec 18, 2023 | 900.00K | - |
Dec 15, 2023 | 900.00K | - |
Dec 14, 2023 | 900.00K | - |
Dec 13, 2023 | 900.00K | - |
Dec 12, 2023 | 900.00K | - |
Dec 11, 2023 | 900.00K | - |
Dec 8, 2023 | 900.00K | -10.00% |
Dec 7, 2023 | 1.00M | -9.09% |
Dec 6, 2023 | 1.10M | - |
Dec 5, 2023 | 1.10M | 10.00% |
Dec 4, 2023 | 1.00M | -16.67% |
Dec 1, 2023 | 1.20M | 20.00% |
Nov 30, 2023 | 1.00M | 25.00% |
Nov 29, 2023 | 800.00K | -11.11% |
Nov 28, 2023 | 900.00K | - |
Nov 27, 2023 | 900.00K | - |
Nov 24, 2023 | 900.00K | 12.50% |
View and export this data all the way back to 2019.
Start Free Trial.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Evogene | 42.46M |
Aspira Women's Health | 42.17M |
BioSig Technologies | 41.85M |
XORTX Therapeutics | 41.56M |
LAVA Therapeutics | 41.54M |
Co-Diagnostics | 40.67M |
Cara Therapeutics | 40.48M |
Neurogene | 40.40M |